Prostate cancers with castration resistance particularly, constitutes of many oncogenic mutations in AR such as high levels of expression, augmented copy number, alterations that affect specificity of ligand, and high level of enzyme activity involving antigen synthesis [120]. This evidence concerns the gene AR and Familial prostate cancer.